Skip to main content
Premium Trial:

Request an Annual Quote

Inpharmatica Closes Financing Round Led By Reed Elsevier

NEW YORK, Nov. 8 (GenomeWeb News) - Inpharmatica said today that it has completed a £13.9 million ($25.8 million) round of financing.


According to Inpharmatica, the financing will be used to further develop the company's in-house and collaborative drug discovery business, and to boost licensing activities for its PharmaCarta drug discovery informatics platform. According to an Inpharmatica spokesman, the platform generates close to $10 million a year in licensing revenues.


Inpharmatica said that the financing was led by Reed Elsevier ventures, the venture arm of publisher Reed Elsevier, which invested £5 million in the round. The companies already have a relationship, with Elsevier subsidiary MDL Information Systems having signed on in February as a non-exclusive distributor of Inpharmatica's Biopendium proteome annotation database.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.